newsfilter
← Latest News
GlobeNewswire·

China National Intellectual Property Administration Grants New Patent Covering DUET-02, One of Three Key CpG-STAT3 Inhibitors Comprising the Duet Platform

New patent covers compound and composition and methods of use forCpG-STAT3 Antisense inhibitor (CpG-STAT3ASO) New patent positions Scopus BioPharma's Subsidiary — Duet Therapeutics — to pursue opportunities arising from China's burgeoning biotech